Our Mission

NASCSA's mission is to support, equip, and advocate for state controlled substances authorities, prescription monitoring program administrators, and other members in their work to advance the public's health, safety and welfare.

Visit NASCSA forum/newsgroup

Important News & Announcements

FDA Delays Enforcement of Drug Supply Chain Security Act

Posted 8/29/2023

WASHINGTON, DC ? Yesterday (August 28, 2023) The Food and Drug Administration announced that it was postponing its plans to enforce the Drug Supply Chain Security Act, slated to go into effect in late November. In its announcement FDA indicated it will not take action until...
Read More

DEA Issues Final Rule on Partial Filling of Schedule II Prescriptions

Posted 7/23/2023

July 21, 2023 - On July 22, 2016, the Comprehensive Addiction and Recovery Act of 2016 (CARA) was signed into law. One provision of CARA amended the Controlled Substances Act to allow the partial filling of schedule II prescriptions under certain conditions. DEA last week...
Read More

SAMHSA Harm Reduction Framework Draft Open for Public Comment

Posted 7/18/2023

Monday - July 16, 2023 - The Substance Abuse Mental Health Services Administration (SAMHSA)  announced that the agency's Harm Reduction Framework Draft is now open for public comment. The framework will inform SAMHSA's harm reduction activities, as well as related policies, programs, and...
Read More

DEA Releases Updated Prescriber Manual

Posted 7/13/2023

On June 14, 2023, DEA posted its newly revised Practitioner?s Manual on its Diversion website. A copy of the guide is attached to this email for your convenience. The manual is current and includes the recent elimination of the requirement for a special registration to treat opioid use disorder...
Read More

DEA Revises Its Rules Regarding Theft/Loss of Controlled Substances

Posted 7/3/2023

DEA just published a final rule amending its theft and loss reporting regulations to require registrants to submit a ?Report of Theft or Loss of Controlled Substances,? DEA Form 106 (?DEA-106?), electronically to the agency within 45 days of discovery of a theft or significant loss. Reporting...
Read More

All news & announcements

Sponsor Spotlight

COMPASS Pathways

COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors

State Controlled Substance and PMP Database

Click on a state to access the controlled substance and PMP database. Available information includes PMP and controlled substance contact information as well as PMP profiles. The database contains the most current information that is available to us.

Please use this form to contact NASCSA

* Please do not submit patient health information (PHI).